PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
In laboratory research, PT-141 is valued for its receptor-targeted activity, particularly its interaction with melanocortin receptor subtypes. These receptors are distributed throughout the central nervous system and peripheral tissues, making PT-141 a relevant tool for exploring peptide-mediated signaling mechanisms.
One of the defining characteristics of PT-141 is its enhanced stability and receptor selectivity compared to endogenous melanocortin peptides. This allows researchers to observe precise signaling effects over controlled experimental periods, supporting reproducible laboratory results.
PT-141 is frequently included in studies examining neuropeptide signaling and central nervous system modulation. Its activity provides insight into how targeted peptide-receptor interactions influence communication between neural circuits in experimental models.
The peptide is also studied for its effects on downstream molecular pathways associated with melanocortin signaling. Researchers investigate how PT-141 impacts gene expression, cellular activation, and receptor-mediated signal transduction under controlled conditions.
PT-141’s compact structure contributes to predictable molecular behavior in laboratory settings, making it suitable for comparative studies and protocol standardization.
Researchers often examine PT-141 alongside other melanocortin analogs to explore differences in receptor affinity, signaling intensity, and activation duration. This comparative approach helps clarify structure–activity relationships in peptide biology.
Unlike broad-acting compounds, PT-141 operates through selective receptor modulation, providing precise research control over the pathways of interest rather than widespread systemic effects.
PT-141 is also used in studies investigating central versus peripheral peptide signaling. Its receptor-targeted design allows differentiation between signaling effects in various tissue types within experimental models.
Because melanocortin signaling intersects multiple biological systems, PT-141 is frequently employed in systems-based research to study integrated cellular responses rather than isolated pathways.
The peptide’s well-characterized profile supports reproducibility and standardization in laboratory research. Its stability, selectivity, and receptor-targeted behavior make it a valuable tool for advanced neuroendocrine and peptide research.
PT-141 continues to attract scientific interest due to its precision, structural refinement, and relevance in understanding complex peptide-mediated signaling networks.
Its targeted design, predictable behavior, and receptor specificity make PT-141 an important research compound for studying central nervous system communication and peptide receptor biology.
New
PT-141 (Bremelanotide) 10mg
$58.00
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
Description
Shipping & Delivery
Related products
BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500 (Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
GHK-Cu 50mg Copper Peptide
GHK-Cu is a small, naturally occurring peptide with the ability to attenuate inflammation, improve antioxidant responses, and improve gene expression on a large scale. Research shows that this copper-chelating peptide may be of critical importance both in the prevention of neurodegenerative disease and as a tool for exploring pathophysiological mechanisms. Studies in mice have revealed that GHK-Cu can protect against neurological insults, improve wound healing, reduce rates of infection, and boost blood vessel growth. The peptide has been of interest in recent years for its anti-oxidant properties that, in combination with its ability to alter gene expression patterns, appear to help slow or even reverse some aspects of aging.
Reviews
There are no reviews yet.